Inhaled corticosteroid use during pregnancy among women with asthma: A systematic review and meta-analysis.

Annelies L Robijn Megan E JensenKaren McLaughlinPeter G Gibson Vanessa E Murphy

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2019)

The prevalence of ICS use among pregnant women with asthma is 41% and varies widely between countries and continents, and prescription rates for ICS change throughout pregnancy. More studies are needed to investigate ICS adherence during pregnancy in women with asthma.

Keyphrases

chronic obstructive pulmonary disease
lung function
allergic rhinitis
cystic fibrosis
risk factors
type diabetes
preterm birth
air pollution
metabolic syndrome
insulin resistance
skeletal muscle